“TAT-Modified Martentoxin Peptide Shows Promise as Antiepileptic Drug by Crossing Blood-Brain Barrier and Displaying Antiseizure Activities”

https://pubmed.ncbi.nlm.nih.gov/38112732

The study found that a TAT-modified version of the Martentoxin peptide, MTX-C-TAT, displayed significant intravenous antiseizure activities by crossing the blood-brain barrier, suggesting its potential as a future antiepileptic drug.